Peripheral neuropathy treatment gets FDA OK for clinical trials
CeNeRx BioPharma's investigational new drug application on a compound aimed at treating peripheral neuropathy has been approved by the U.S. Food and Drug Administration. The Cary, North Carolina-based company is now preparing to move forward in human trials of the compound.
